Home > Share Market > Stocks > Natco Pharma Ltd > Financial Statements > NATCOPHARM Cash Flow

Natco Pharma Ltd Financial Statements

Natco Pharma Ltd Cash Flow Statement

  • Tabular Data
  • Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 580 569 887 624
Depreciation (117) (100) (66) (54)
Tax paid (137) (111) (192) (140)
Working capital 1,787 1,769 1,459 450
Other operating items -- -- -- --
Operating cashflow 2,112 2,128 2,088 881
Capital expenditure 2,328 1,708 681 339
Free cash flow 4,440 3,836 2,768 1,219
Equity raised 4,091 3,851 2,999 1,941
Investments 241 49.80 74.20 30.30
Debt financing/disposal 193 77.60 (54) (3.50)
Dividends paid 114 127 152 118
Other items -- -- -- --
Net in cash 9,078 7,942 5,940 3,304

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000